INOVIO PHARMACEUTICALS
INOVIO is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure, and protect people from diseases associated with HPV, cancer, and infectious diseases. INOVIO is the first and only company to have clinically demonstrated that DNA medicine can be delivered directly into cells in the body via a proprietary smart device to produce a robust and tolerable immune response. Specifically, INOVIO's lead candidate VGX-3100, currently in Phase 3 trials for precancerous cervical dysplasia, demonstrated it destroyed and cleared high-risk HPV 16 and 18 in a Phase 2b clinical trial. High-risk HPV is responsible for 70% of cervical cancer, 90% of anal cancer, and 69% of vulvar cancer.
INOVIO PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
1979-01-01
Address:
Plymouth Meeting, Pennsylvania, United States
Country:
United States
Website Url:
http://www.inovio.com
Total Employee:
251+
Status:
Active
Contact:
267-440-4200
Email Addresses:
[email protected]
Total Funding:
446.38 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Rigel Pharmaceuticals
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
Neovacs
Neovacs, a biotech company, develops several therapeutic vaccines for the treatment of AIDS, cancer and auto-immune and allergic diseases.
Next Heathcare
Next Healthcare is a biotechnology service that enables customers to bank their skin and stem cells for use in future treatments.
Neurocrine Biosciences
Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases.
NantKwest
NantKwest is a clinical-stage immunotherapy company focused on harnessing the immune system to treat disease.
Verseon
Verseon’s breakthroughs in computational chemistry, AI, & synthesis create novel pharmaceuticals. Atom by atom, we drive innovation.
Vascular Therapies
Vascular Therapies is a biopharma company that aims to improve vascular surgery outcomes in patients with kidney and vascular diseases.
Verona Pharma
Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.
Vivakor
Vivakor is a biomedical company that focuses on the R&D of a range of medical devices and pharmaceuticals to improve human health.
Vaccinogen
Vaccinogen manufactures vaccines and other immunotherapeutic products for cancers and infectious diseases.
Viralytics
Viralytics is an Australian biotechnology company, listed on the Australian Stock Exchange (ASX:VLA) and is quoted on the OTC market
MediGene
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
Milo Biotechnology
Milo Biotechnology develops technologies and programs to improve the lives of patients with neuromuscular diseases.
Lucy Therapeutics
Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria.
Advanced Accelerator Applications
AAA is an innovative medicines company focused on the development of targeted radioligand therapies and precision imaging radioligands.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
AKESOgen
AKESOgen is a biomarker, genomics, and pharmacogenomics contract research organization.
AC Immune
AC Immune is a biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials
Affinity Therapeutics
Affinity Therapeutics is a research-driven biotech company focusing on the design and delivery of life-enhancing medical applications.
AGTC
AGTC is a biotechnology company conducting human clinical trials of AAV-based gene therapies for the treatment of rare diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Anthera Pharmaceuticals
Anthera Pharmaceuticals is focused on developing products to treat diseases associated with inflammation and autoimmune diseases.
Arena Pharmaceuticals
Arena Pharmaceuticals is focused on delivering solutions for cardiovascular, central nervous system, inflammatory and metabolic diseases.
Alternative Plants
Hidden botanical treasures - active ingredients from rare medicinal plants made accessible by our plant stem cell technology
Arvinas
Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
Ankyrbio
AnkyrBio is a biotechnology company focused on commercializing its proprietary anchoring system.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Adverum Biotechnologies
Adverum Biotechnologies is a gene therapy company that focuses on developing medicines that can offer therapeutic benefits to patients.
Adheron Therapeutics
Adheron is a biotechnology company focused on leveraging pioneering technology that disrupts cell adhesion to treat a variety of diseases.
Auransa
A clinical stage drug development company who aims to invent novel drugs for hard-to-treat diseases using its proprietary AI platform
Aridis Pharmaceuticals
Aridis is a biopharmaceutical company focused on the development of novel, differentiated therapies for infectious diseases.
Amgen
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illness and diseases.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Altor BioScience
Altor BioScience researches and develops immunotherapeutic agents for the treatment of cancer, viral infections and autoimmune diseases.
Endologix
Endologix is a developer and manufacturer of minimally invasive treatments for aortic disorders.
Exelixis
Exelixis works is focused on discovering, developing and commercializing therapies for the treatment of cancer and other serious diseases.
Biogen Idec
Biogen Idec is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
Braeburn
Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder.
Bio-Path Holdings
Bio-Path Holdings is a biotechnology company developing therapeutic products for the liposomal delivery of nucleic acids in cancer patients.
Beryllium Discovery
Beryllium Discovery is a specialized drug discovery contract research organization (CRO), provides research services.
Blueberry Therapeutics
Blueberry Therapeutics focuses on developing medicines for inflammatory and infectious diseases.
BioViva
BioViva creates regenerative medicine to alleviate diseases caused by cellular degeneration and genetic disorders.
FluGen
FluGen is a biopharmaceutical company specializing on the prevention and treatment of seasonal and pandemic influenza worldwide.
Tosk
Tosk is a biopharmaceutical company dedicated to improving the safety of drugs for diseases such as cancer, arthritis, and psoriasis.
TOMI Environmental Solutions
TOMI Environmental Solutions is a bacteria decontamination and infectious disease control company.
USMD
USMD Holdings develops, operates and manages entities that deliver diagnostic, therapeutic and hospital-based health care to patients.
UDAMO
Udamo is a digital therapeutics company focusing on the automation of Cognitive Behavioural Therapy (CBT) interventions
Synthetic Biologics
Synthetic Biologics is a biotechnology company developing biologics for the prevention and treatment of serious infectious diseases.
Sanofi Genzyme
Sanofi Genzyme, the specialty care business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology.
Sonnet BioTherapeutics
Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.
Senex Biotechnology
Senex Biotechnology is engaged in discovering and developing therapeutic agents to treat cancer, viral diseases, and age-related diseases.
SteadyMed Therapeutics
SteadyMed is a media-device company developing injectable therapeutic drugs for pain relief, diabetes and other chronic conditions.
Seagen
Seagen is dedicated to improving patient outcomes with advanced antibody-drug conjugate technology.
Sangamo Therapeutics
Sangamo researches, develops and commercializes engineered DNA-binding proteins for the development of novel therapeutic strategies.
Sequoia Sciences
Sequoia Sciences is a pharmaceutical company discovering and developing new medicines for the treatment of bacterial infections and cancers.
SyntheX
SyntheX is a biotechnology company reimagining precision therapeutics with new drug discovery technologies focused on protein modulation.
Superior Biologics
Superior Biologics is a leading home infusion and specialty pharmacy provider offering services to pediatric & adult populations suffering.
Windtree Therapeutics
Windtree is a clinical-stage focused on developing novel surfactant therapies for respiratory diseases and other potential applications.
Harbour Antibodies
Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.
Hepregen
Hepregen Corporation is a biotechnology company that focuses on understanding the metabolism of drugs in the liver.
Cigna HealthSpring
HealthSpring is a health service company offering personalized healthcare solutions for Medicare and Medicaid beneficiaries in the U.S.
Integrated BioTherapeutics
AIntegrated BioTherapeutics is a focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases.
Inmedix
Inmedix brings cloud-based clinical diagnostics and immuno-autonomics to medicine to improve outcomes in autoimmune diseases.
Immunovative Therapies
Immunovative Therapies is an Israeli company specializing in using living immune cells for the treatment of cancer and infectious diseases.
IMV Inc
IMV Inc applies its novel platform to the development of vaccines for cancer therapy, infectious diseases, and animal health.
IntegraGen
IntegraGen is a biotechnology company developing molecular markers for central nervous system and metabolic diseases.
Inception Sciences
Inception Sciences creates therapies with transformative potential to address diseases and disorders with significant unmet need.
ioGenetics
ioGenetics is a biotechnology company that develops therapeutics, vaccines, and diagnostics for infectious diseases.
ICB International
ICB International is a biomedicine company offering a blood-brain barrier platform for diseases of the central nervous system.
Imcyse
Developing disease specific immune therapies to treat severe, chronic auto-immune, inflammatory, allergic, infectious diseases and tumors.
Gemmus Pharma
Gemmus develops innovative pharmaceutical products for the treatment of influenza and other viral infectious diseases.
Greenteaspoon
Greenteaspoon is a biotechnology company developing prebiotics and probiotics that harness the power of the microbiome.
Gamida Cell
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases.
Oncolytics Biotech
Oncolytics Biotech develops oncolytic viruses as potential therapeutics for use in a broad range of cancers.
Olatec Therapeutics LLC
clinical stage biotech developing a new class of antiinflammatory therapeutics to address a broad spectrum of diseases by targeting NLRP3
Xortx Therapeutics
XORTX Therapeutics is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease
Zai Lab
Zai Lab brings transformative medicines for cancer, autoimmune, and infectious diseases to patients in China and around the world.
ZebiAI
ZebiAI is a platform that applies massive experimental DNA encoded library data sets to power machine learning for drug discovery.
Cara Therapeutics
Cara Therapeutics is a biotechnology company focused on developing therapeutics to treat diseases associated with pain and inflammation.
Covis Pharma
Covis Pharma markets therapeutic solutions for patients with life threatening and other serious medical conditions.
Cardax Pharma
Cardax Pharma offers small molecule therapies for unmet medical needs such as hepatitis, arthritis, cardiovascular diseases, and more.
Cebix
Cebix is a biopharmaceutical company developing treatments for diabetic complications that affect the function of nerves, kidneys and eyes.
CardioFocus
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.
Cordant Health Solutions
Cordant Health Solutions is a provider of drug testing services to groundbreaking solutions for payers, clinicians, and organizations.
Cognoa
Cognoa is a behavioral health company.
Strongbridge Biopharma
Strongbridge Biopharma is a clinical and financial foundation to connect patients with new treatments for rare diseases.
Cytodyn
CytoDyn is a biotechnology company that focuses on the development of new therapies to combat infections with immune deficiency viruses.
Cellworks
Cellworks is a life sciences technology company involved in drug and bio-marker discovery and researches in therapeutic areas.
centrose
Centrose is a biotechnology company engaged in the development and commercialization of therapeutics targeting disease related cells.
Catalyst Biosciences
Catalyst Biosciences is a drug r and d company creating catalytic biopharmaceutical products based on engineered human proteases.
Protein Alternatives
ProAlt is young biotech company developing innovative products for the detection and treatment of cancers.
PharmatrophiX
PharmatrophiX is a biotech company focused on developing therapeutic drugs to prevent neurodegenerative diseases.
Precise Light Surgical
Precise Light Surgical was incorporated in 2008 and is based in Sunnyvale, California.
Vivoryon Therapeutics
Vivoryon is a clinical stage company focused on bringing first-in-class therapies to patients suffering from age-related diseases.
PDS Biotechnology Corporation
PDS Biotechnology Announces Treatment of First Patient with PDS0101.
ProThera Biologics
ProThera Biologics focuses on unmet medical needs by developing integrated theranostic and therapeutic biomolecules.
Paion
PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
Helomics
Helomics provides comprehensive tumor profiling utilizing proprietary tissue-based live cell and fixed cell products and services.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-05-02 | Bioject Medical Technologies | Bioject Medical Technologies acquired by Inovio Pharmaceuticals | 4.3 M USD |
| 2005-02-01 | Inovio AS | Inovio AS acquired by Inovio Pharmaceuticals | N/A |
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Inovio Pharmaceuticals
Coalition for Epidemic Preparedness Innovations
Coalition for Epidemic Preparedness Innovations investment in Grant - Inovio Pharmaceuticals
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Inovio Pharmaceuticals
Coalition for Epidemic Preparedness Innovations
Coalition for Epidemic Preparedness Innovations investment in Grant - Inovio Pharmaceuticals
Korea Investment Partners
Korea Investment Partners investment in Post-IPO Debt - Inovio Pharmaceuticals
Defense Threat Reduction Agency (DTRA)
Defense Threat Reduction Agency (DTRA) investment in Grant - Inovio Pharmaceuticals
DARPA
DARPA investment in Grant - Inovio Pharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-24 | Geneos Therapeutics | Inovio Pharmaceuticals investment in Series A - Geneos Therapeutics | 17 M USD |
| 2021-03-03 | Geneos Therapeutics | Inovio Pharmaceuticals investment in Series A - Geneos Therapeutics | 12 M USD |
| 2019-02-21 | Geneos Therapeutics | Inovio Pharmaceuticals investment in Series A - Geneos Therapeutics | 10.5 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-27 | INOVIO Appoints Dr. Michael Sumner, MB BS, MBA as Chief Medical Officer |
| 2022-05-10 | INOVIO Announces the Appointment of Jacqueline Shea, Ph.D., as Chief Executive Officer |
Official Site Inspections
http://www.inovio.com Semrush global rank: 1.25 M Semrush visits lastest month: 23.96 K
- Host name: 20.245.221.239
- IP address: 20.245.221.239
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Inovio Pharmaceuticals"
Inovio Pharmaceuticals - Wikipedia
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than …See details»
Inovio Pharmaceuticals, Inc. - INVESTORS & MEDIA
INOVIO's Board of Directors has five standing committees. Each committee member meets the independence requirements of the NASDAQ, the definition of a "non-employee director" under …See details»
Leadership | INOVIO Pharmaceuticals
She led INOVIO’s manufacturing, commercial, business development, project and alliance management operations. Dr. Shea has more than 25 years of experience in the life sciences …See details»
Inovio Pharmaceuticals, Inc. - INVESTORS & MEDIA
Nov 14, 2024 INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, …See details»
Org Chart Inovio Pharmaceuticals - The Official Board
Organizational Chart of Inovio Pharmaceuticals. Inovio Pharmaceuticals www.inovio.com. has 22 executives +1 267 440 4200; Add an executive. Inovio Pharmaceuticals (INO) News . Anything missing? We search for you. Print or …See details»
About Inovio | INOVIO Pharmaceuticals
About INOVIO . Purpose, Mission and Values; Leadership; Partnerships; DNA Medicines Technology . Optimized Plasmid Design and Delivery; DNA Medicines Explained; The …See details»
Inovio Pharmaceuticals - Crunchbase Company Profile …
INOVIO is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure, and protect people from diseases associated with HPV, cancer, and infectious diseases. INOVIO is the …See details»
Inovio Pharmaceuticals, Inc. - INOVIO Announces Corporate ...
Jul 19, 2022 "By driving operational efficiencies throughout our organization, we are focused on advancing our lead pipeline candidates toward commercialization and optimizing our chances …See details»
INOVIO Announces Corporate Reorganization to Reduce …
Jul 19, 2022 INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to potentially treat and protect people from infectious diseases, cancer, and …See details»
Purpose, Mission and Values | INOVIO Pharmaceuticals
INOVIO is a clinical-stage biotechnology company committed to advancing DNA medicines to help save and protect lives worldwide. We are trailblazers in the DNA medicine field, working …See details»
Inovio Pharmaceuticals, Inc. (INO) - Yahoo Finance
Inovio Pharmaceuticals Third Quarter 2024 Earnings: US$0.89 loss per share (vs US$1.52 loss in 3Q 2023) Simply Wall St. • 20 days ago Inovio Pharmaceuticals Inc (INO) Q3 2024 Earnings …See details»
Inovio Pharmaceuticals, Inc. - INOVIO Announces Strategic ...
Jan 31, 2023 Cost-saving measures include 11% headcount reduction Annual savings expected to be approximately $4.3 million Data readouts expected in first quarter of 2023 for key …See details»
Inovio COVID-19 vaccine - Wikipedia
On 26 August 2021 Inovio's global Phase 3 efficacy trial receives authorization to proceed from Brazil. [10] On 26 October 2021 The World Health Organization launched a Global Covid-19 …See details»
INOVIO Announces Further Reorganization, Continues Focus on …
Jan 31, 2023 INOVIO Pharmaceuticals (NASDAQ: INO) announced a strategic reorganization expected to provide annual savings of approximately $4.3 million and includes an 11% …See details»
Inovio Pharmaceuticals, Inc. - INOVIO Expands Executive …
PLYMOUTH MEETING, Pa., Nov. 5, 2021 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to …See details»
Partners - Inovio Payments
Implementing Inovio’s payment technology into your business can lead to big things. For you control freaks out there, our flexible partnership programs allow any size organization to create …See details»
Home | INOVIO Pharmaceuticals
SUBSCRIBE FOR UPDATES FROM INOVIO Register to receive email alerts for INOVIO press releasesSee details»
INOVIO Reports Inducement Grants Under Inducement Plan
Oct 2, 2024 INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, …See details»
Partnerships | INOVIO Pharmaceuticals
INOVIO is proud to partner with experts across industry, academia and government to help drive innovation and advance the development of promising DNA Medicine candidates. Some of our …See details»